Global impact of mcr-1-positive Enterobacteriaceae bacteria on "one health". (2nd September 2020)

• Record Type: Journal Article
• Authors: Xiaomin, Shi; Yiming, Li; Yuying, Yang; Zhangqi, Shen; Yongning, Wu; Shaolin, Wang
• Is Part Of: Critical reviews in microbiology. Volume 46:Number 5(2020)
• Page Start: 565
• Page End: 577
• Publication Date: 2020-09-02
• Subjects: Polymyxins -- mcr-1 -- animal -- human -- environment; Microbiology -- Periodicals; Microbiology -- Periodicals; Review Literature -- Periodicals; 579
• DOI: 10.1080/1040841X.2020.1812510
• Languages: English
• ISSNs: 1040-841X

Abstract

Abstract: Polymyxins, especially polymyxin B and polymyxin E (colistin), are considered to be the last line of defence against infections caused by multi-drug-resistant (MDR) gram-negative bacteria such as carbapenem-resistant Enterobacteriaceae (CRE). However, the recent emergence and dissemination of the plasmid-mediated colistin resistance gene mcr-1 and its variants pose a serious challenge to public health and the livestock industry. This review describes the prevalence and dissemination of mcr-1 -positive isolates from different sources, including animals (food animals, pet animals and wildlife), humans (healthy populations and patients) and the environment (farms, urban and rural communities and natural environments) based on existing epidemiological studies of mcr-1 and MCR-1-producing Enterobacteriaceae bacteria around the world. The major mechanisms of mcr-1 transmission across humans, animals and the environment are discussed.